Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy
Youmin Pu, Huan Chang, Wei Chen, Huhai Zhang, Wenjie Chen, Hongwen Zhao et al. Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy. // Functional & Integrative Genomics. – 2026. – DOI: 10.1007/s10142-026-02052-2. – URL: https://doi.org/10.1007/s10142-026-02052-2
Youmin Pu, Huan Chang, Wei Chen, Huhai Zhang, Wenjie Chen, Hongwen Zhao, & Daodong Sun (2026). Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy. Functional & Integrative Genomics. https://doi.org/10.1007/s10142-026-02052-2
Youmin Pu, et al. “Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy.” Functional & Integrative Genomics, 2026. doi:10.1007/s10142-026-02052-2.
@article{Pu2026,
title = {Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy},
author = {Pu, Youmin and Chang, Huan and Chen, Wei and Zhang, Huhai and Chen, Wenjie and Zhao, Hongwen and Sun, Daodong},
journal = {Functional \& Integrative Genomics},
year = {2026},
doi = {10.1007/s10142-026-02052-2},
url = {https://doi.org/10.1007/s10142-026-02052-2}
}